Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Future research in integrating AI and IoT to improve digital twin applications in precision medication could be a transformative step
GLP analogs do not damage the kidneys, but there have been cases of acute renal failure due to dehydration secondary to vomiting/diarrhea
At a glance GLP-1 medications are changing how consumers eat, with appetite suppression, smaller portions and altered taste preferences driving demand for nutrient-dense, high-protein foods Brands can lead through smarter reformulation, offering products fortified with protein, fibre and clean label sweeteners to help consumers stay nourished on fewer calories Improving nutrient density can drive opportunity high-protein, high fibre, portion-controlled foods and beverages align with new consumer priorities for long-term weight and wellness management Innovation spans multiple categories, with bakery, snacks and beverages being ideal platforms for nutrient-dense reformulations that balance functionality, taste and texture Ingredion's portfolio of resistant starches, prebiotic fibres, pulse proteins and low- and no-calorie sweeteners help formulators meet the evolving nutritional needs of consumers on GLP-1 based medications as well as those looking to manage their weight without pharmaceuticals Weight management trends are redefining nutrition and pushing brands to reformulate For food and beverage brands, this shift represents far more than a dietary trend
Novo Nordisk shipped approximately 46 million Wegovy pens globally in 2025
